ViroGates A/S (CPH:VIRO)
Denmark · Delayed Price · Currency is DKK 10.60
+0.40 (3.92%)
Jun 17, 2026, 1:31 PM CET
ViroGates Market Cap
ViroGates has a market cap or net worth of 98.39 million as of June 17, 2026. Its market cap has increased by 98.14% in one year.
Market Cap
98.39M
Enterprise Value
80.33M
Revenue
9.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.60
Market Cap Chart
Since June 26, 2018, ViroGates's market cap has decreased from 259.22M to 98.39M, a decrease of -62.04%. That is a compound annual growth rate of -11.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 98.39M | -21.19% |
| Dec 30, 2025 | 124.84M | 52.27% |
| Dec 30, 2024 | 81.99M | 111.23% |
| Dec 29, 2023 | 38.81M | -71.09% |
| Dec 30, 2022 | 134.25M | -70.57% |
| Dec 30, 2021 | 456.12M | 79.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.24T |
| Genmab | 97.86B |
| Coloplast | 85.56B |
| ALK-Abelló | 57.47B |
| Gubra | 5.71B |
| BioPorto | 574.33M |
| Pharma Equity Group | 108.02M |
| Scandinavian Medical Solutions | 77.86M |